Misclassification of VLCAD carriers due to variable confirmatory testing after a positive NBS result
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Community Genetics"
DOI: 10.1007/s12687-019-00409-8
Abstract: The Iowa Newborn Screening (NBS) Program began screening for very long-chain acyl-CoA dehydrogenase deficiency (VLCAD) in 2003. Untreated VLCAD can lead to liver failure, heart failure, and death. Current confirmatory testing recommendations by the American… read more here.
Keywords: vlcad; misclassification vlcad; confirmatory testing; vlcad carriers ... See more keywords